Your browser doesn't support javascript.
loading
A second hit? Pulmonary arterial hypertension, BMPR2 mutation, and exposure to prescription amphetamines.
Jaliawala, Huzaifa A; Parmar, Miloni; Summers, Katherine; Bernardo, Roberto J.
Afiliação
  • Jaliawala HA; Division of Pulmonary, Critical Care and Sleep Medicine University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA.
  • Parmar M; Department of Internal Medicine University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA.
  • Summers K; Department of Pharmacy Oklahoma University Medical Center Oklahoma City Oklahoma USA.
  • Bernardo RJ; Division of Pulmonary, Critical Care and Sleep Medicine University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA.
Pulm Circ ; 12(1): e12053, 2022 Jan.
Article em En | MEDLINE | ID: mdl-35506068
ABSTRACT
The second hit hypothesis in pulmonary hypertension refers to the development of pulmonary vascular disease in individuals at risk, after an additional exposure or "hit" to factors with potential injury to the pulmonary circulation, such as drugs or toxins. We here present a case of severe pulmonary hypertension diagnosed during the third trimester of pregnancy, in a patient with familial history of pulmonary hypertension, found to have a heterozygous mutation in the BMPR2 gene, who also had chronic exposure to prescription amphetamines. We hypothesize that exposure to prescription amphetamines could act as a second hit of pulmonary vascular injury in individuals at risk of pulmonary vascular disease.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article